Detalhe da pesquisa
1.
COVID-19 and Diabetes.
Annu Rev Med
; 73: 129-147, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379444
2.
Cardiovascular and Renal Outcomes With Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Combination Therapy: A Meta-Analysis of Randomized Cardiovascular Outcome Trials.
Endocr Pract
; 29(7): 509-516, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037286
3.
Role and Significance of Dietary Protein in the Management of Type 2 Diabetes and Its Complications in India: An Expert Opinion.
J Assoc Physicians India
; 71(12): 36-46, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736053
4.
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
J Assoc Physicians India
; 71(12): 62-74, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736056
5.
Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India.
J Assoc Physicians India
; 69(9): 11-12, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585892
6.
Expert Group Recommendations on Detection and Management of Hypoglycemia in Routine Clinical Practice in Insulin Treated Patients with Diabetes.
J Assoc Physicians India
; 66(12): 90-97, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31313564
7.
Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
Endocr Pract
; 28(10): 1107-1108, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820610
8.
Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?"
J Assoc Physicians India
; 65(7): 51-62, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792170
9.
Consensus on Initiation and Intensification of Premix Insulin in Type 2 Diabetes Management.
J Assoc Physicians India
; 65(4): 59-73, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28527166
10.
Review of Clinical Profile of IDegAsp.
J Assoc Physicians India
; 63(5 Suppl): 15-20, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26548030
11.
Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence.
Diabetes Metab Syndr
; 18(5): 103024, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718449
12.
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.
Expert Rev Clin Pharmacol
; 17(4): 349-362, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471973
13.
Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal.
Diabetes Metab Syndr
; 17(4): 102747, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966544
14.
Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials.
Diabetes Metab Syndr
; 17(2): 102710, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702046
15.
New-onset diabetes with sodium-glucose cotransporter-2 inhibitors in prediabetes: An updated meta-analysis and possible mechanisms.
Diabetes Metab Syndr
; 17(6): 102789, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257223
16.
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.
J Diabetes
; 15(2): 86-96, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690377
17.
Non-sugar sweeteners and health outcomes in adults without diabetes: deciphering the WHO recommendations in the Indian context.
Diabetes Metab Syndr
; 17(8): 102829, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451112
18.
Protein restriction in adults with chronic kidney disease, with or without diabetes: Integrated Diabetes and Endocrine Academy (IDEA) consensus statement for Indian patients.
Diabetes Metab Syndr
; 17(5): 102785, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210963
19.
Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement.
J Pediatr Endocrinol Metab
; 36(1): 4-18, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36424806
20.
"Risk assessment for periodontal disease associated tooth loss among rural and urban population of 35-44, 45-54, 55-64 and 65-74 years age groups of Barabanki district, Uttar Pradesh, India: An epidemiological study.
Natl J Maxillofac Surg
; 13(Suppl 1): S70-S75, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36393949